Journal of Comparative Effectiveness Research

Papers
(The H4-Index of Journal of Comparative Effectiveness Research is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants86
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study78
Efficacy classification of modern therapies in multiple sclerosis58
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis44
The prevalence, characteristics and treatment of hemorrhoidal disease: results of an international web-based survey40
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy38
Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements36
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance31
Evidence-based public policy making for medicines across countries: findings and implications for the future29
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients27
Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials26
Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost–effectiveness analysis24
COVID-19 complications in males and females: recent developments20
The use of nonrandomized evidence to estimate treatment effects in health technology assessment18
Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study18
Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-201918
0.052903890609741